![Rafael Amado](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rafael Amado
President at
ZAI LAB LIMITED
Net worth: 1 M $ as of 2026-06-29
Profile
Presently, Rafael G. Amado occupies the position of Chief Medical Officer, EVP-Research & Development at Allogene Therapeutics, Inc. In the past he was President-Research & Development at Adaptimmune Therapeutics Plc, Senior Vice President at GlaxoSmithKline Plc, Executive Director-Therapeutic Oncology at Amgen Ltd. and Assistant Clinical Professor at the University of California, Los Angeles. Rafael G. Amado received a doctorate from the University of Seville.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ZAI LAB LTD. 0.05% | 2026-04-09 | 570,220 ( 0.05% ) | 1 M $ | 2026-06-29 |
Rafael Amado active positions
| Companies | Position | Start |
|---|---|---|
| ZAI LAB LIMITED | President | 2022-11-30 |
Former positions of Rafael Amado
| Companies | Position | End |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Director/Board Member | 2025-01-07 |
| ALLOGENE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-12-29 |
| ADAPTIMMUNE THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 2019-08-11 |
Adaptimmune LLC
 Adaptimmune LLC Medical/Nursing ServicesHealth Services Focuses on the use of T cell therapy to treat cancer and infectious disease | Chief Tech/Sci/R&D Officer | 2019-06-30 |
| GSK PLC | Corporate Officer/Principal | 2015-02-28 |
Training of Rafael Amado
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Seville
 University of Seville Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amgen Ltd.
 Amgen Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology firm | Commercial Services |
Adaptimmune LLC
Adaptimmune LLC Medical/Nursing ServicesHealth Services Focuses on the use of T cell therapy to treat cancer and infectious disease | Health Services |
Zai Lab Ltd.
 Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
Poseida Therapeutics, Inc.
 Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Allogene Therapeutics, Inc.
 Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
- Stock Market
- Insiders
- Rafael Amado
